![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Prévisions du marché européen du traitement de l’hématurie jusqu’en 2028 – Impact du COVID-19 et analyse régionale par traitement (médicaments, thérapies et autres), indication (infections des voies urinaires, calculs rénaux, urétrite, cancer du sang, calculs vésicaux, cancer de la prostate, cystite, traumatisme, Exercice vigoureux, maladie polykystique des reins, endométriose et menstruations), type (hématurie macroscopique, hématurie microscopique, hématurie idiopathique et hématurie Jogger\'™), utilisateur final (hôpitaux, cliniques et centres chirurgicaux ambulatoires et autres)
Introduction au marché
L\'hématurie est une condition médicale dans laquelle la présence de sang est détectée dans l\'urine. . Généralement, l\'urine ne contient pas de globules rouges, ce qui peut entraîner de graves problèmes pouvant également provoquer des calculs rénaux, des infections des voies urinaires et d\'autres maladies héréditaires.
De plus, l\'hématurie est à forte prévalence. les indications associées devraient soutenir la croissance du marché au cours de la période de prévision. Cependant, des cas non diagnostiqués d\'indications associées limitent la croissance du marché européen du traitement de l\'hématurie.
De nombreux patients ont signalé une lésion rénale aiguë progressive (IRA) à l\'admission et pendant l\'hospitalisation et de légers symptômes de protéinurie pour l\'hématurie, qui sont associés à des résultats cliniques indésirables chez les patients hospitalisés atteints de COVID 19. La protéinurie et l\'hématurie auraient une prévalence encore plus élevée dans le COVID-19 que dans l\'AKI. Des études rétrospectives menées en Chine ont rapporté que la protéinurie et l’hématurie sont associées au COVID-19 et à une mortalité plus élevée. De plus, selon la base de données COVID19 de l’Association européenne du rein (ERACODA) établie en mars 2020, environ 25 % des patients transplantés rénaux reçoivent un diagnostic de coronavirus. Par conséquent, on s’attend à ce qu’une augmentation du nombre de patients positifs au COVID soient plus susceptibles d’être traités pour une maladie rénale.
Aperçu et dynamique du marché
Le marché européen du traitement de l\'hématurie devrait atteindre 313,8 millions de dollars US d\'ici 2028, contre 270,5 millions de dollars US en 2021 ; il devrait croître à un TCAC de 2,1 % de 2021 à 2028. Les patients de la région préfèrent généralement les services de soins à domicile. Les dispositifs médicaux portables et portables recèlent un potentiel majeur pour améliorer le traitement en permettant aux patients de poursuivre leurs activités quotidiennes parallèlement au processus de dialyse. Par exemple, la dialyse à domicile offre aux patients une plus grande flexibilité en termes d’horaires de travail et de style de vie. De plus, la procédure globale d’hémodialyse à domicile est beaucoup simplifiée par rapport à la dialyse traditionnelle. Ainsi, les dispositifs portables et implantables pourraient offrir aux patients la liberté de travailler et d’effectuer leurs activités quotidiennes pendant le traitement. De telles alternatives thérapeutiques avancées sont susceptibles de stimuler le marché européen du traitement de l\'hématurie dans les années à venir.
Segments clés du marché
En termes de type, le segment de l\'hématurie macroscopique représentait la plus grande part du marché européen du traitement de l\'hématurie en 2020. En termes de traitement, le segment des médicaments représentait la plus grande part de le marché européen du traitement de l\'hématurie en 2020. En termes d\'indication, le segment des infections des voies urinaires représentait la plus grande part du marché européen du traitement de l\'hématurie en 2020. En termes d\'utilisateur final, le segment des hôpitaux représentait la plus grande part du marché européen du traitement de l\'hématurie. marché du traitement en 2020.
Principales sources et entreprises répertoriées
< span> Quelques sources primaires et secondaires majeures mentionnées pour la préparation de ce rapport sur le marché du traitement de l\'hématurie en Europe sont les sites Web des entreprises, les rapports annuels, les rapports financiers, les documents gouvernementaux nationaux et les bases de données statistiques, entre autres. Les principales sociétés répertoriées dans le rapport sont AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd et Boehringer Ingelheim International GmbH.
Rapport Raisons d\'acheter
- Comprendre le paysage du marché européen du traitement de l\'hématurie et identifier les segments de marché qui sont susceptibles de garantir un rendement élevé
- Pour comprendre le paysage du marché en constante évolution et garder une longueur d\'avance sur la concurrence
- Pour être efficace planifier des fusions, des acquisitions et des accords de partenariat sur le marché européen du traitement de l\'hématurie en identifiant les segments avec les ventes probables les plus prometteuses
- Prendre des décisions commerciales éclairées à partir d\'une analyse perspicace et complète du marché performances de divers segments
- Pour obtenir les prévisions de revenus du marché européen du traitement de l\'hématurie en fonction de divers segments pour la période 2021-2028
SEGMENTATION DU MARCHÉ EUROPÉEN DU TRAITEMENT DE L\'HÉMATURIE
Par Traitement
- Médicaments
- Thérapies
- Autres
Par indication
- Infections des voies urinaires
- Calculs rénaux
- Urétrite
- Cancer du sang
- Calculs vésicaux
- Cancer de la prostate
- Cystite
- Traumatisme
- Exercice vigoureux
- Maladie polykystique des reins
- Endométriose
- Menstruation
Par Type
- Hématurie macroscopique
- Hématurie microscopique
- Hématurie idiopathique
- < span>Hématurie de Jogger
Par utilisateur final
< ul>Par pays
- Europe
- Allemagne
- Royaume-Uni
- France
- Espagne
- Italie
- Reste de l\'Europe
Entreprises mentionnées
- < span>AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- < span>Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Hematuria Treatment Market – By Treatment
1.3.2 Europe Hematuria Treatment Market – By Indication
1.3.3 Europe Hematuria Treatment Market – By Type
1.3.4 Europe Hematuria Treatment Market – By End User
1.3.5 Europe Hematuria Treatment Market – By Country
2. Europe Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – Europe Analysis
6.1 Europe Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 Europe Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 Europe Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 Europe Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 Europe Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. Europe Hematuria Treatment Market – Geographic Analysis
11.1 Europe: Hematuria Treatment Market
11.1.1 Overview
11.1.2 Europe: Hematuria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 Europe: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.4 Europe: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.5 Europe: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.6 Europe: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7 Europe: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.1.7.1 Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 Germany: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.1.3 Germany: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.1.4 Germany: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.1.5 Germany: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.2 France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 France: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.2.3 France: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.2.4 France: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.2.5 France: Hematuria Treatment Market, by End user, 2019–2028 (US$ Million)
11.1.7.3 UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 UK: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.3.3 UK: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.3.4 UK: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.3.5 UK: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.4 Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.1 Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.2 Italy: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.4.3 Italy: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.4.4 Italy: Hematuria Treatment Market, by Type, 2019-2028 (US$ Million)
11.1.7.4.5 Italy: Hematuria Treatment Market, by End User, 2019-2028 (US$ Million)
11.1.7.5 Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.1 Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.2 Spain: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.5.3 Spain: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.5.4 Spain: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.5.5 Spain: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.6 Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.1 Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.2 Rest of Europe: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.6.3 Rest of Europe: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.6.4 Rest of Europe: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.6.5 Rest of Europe: Hematuria Treatment Market, By End User, 2019–2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 2. Europe: Hematuria Treatment Market, By Indication– Revenue and Forecast to 2028 (US$ Million)
Table 3. Europe Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. Europe Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Germany: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Hematuria Treatment Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 13. UK: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 14. UK: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 15. UK: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Spain: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 22. Spain: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 23. Spain: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Spain: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Europe: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Europe: Hematuria Treatment Market, By Indication– Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Europe: Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Europe: Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 29. Organic Developments Done by Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. Europe Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. UK to Show Significant Growth During Forecast Period
Figure 5. Europe Hematuria Treatment Market, Industry Landscape
Figure 6. Europe PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Europe Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. Europe Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. Europe Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. Europe Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. Europe: Hematuria Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 37. Europe Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Europe: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 39. Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Impact Of COVID-19 Pandemic in Europe Country Markets
Figure 46. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.